Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Phibro Anl Htlh A (PAHC)

Phibro Anl Htlh A (PAHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 990,703
  • Shares Outstanding, K 40,503
  • Annual Sales, $ 1,018 M
  • Annual Income, $ 2,420 K
  • EBIT $ 72 M
  • EBITDA $ 109 M
  • 60-Month Beta 0.51
  • Price/Sales 0.99
  • Price/Cash Flow 11.78
  • Price/Book 3.90

Options Overview Details

View History
  • Implied Volatility 57.17% ( -19.22%)
  • Historical Volatility 37.57%
  • IV Percentile 64%
  • IV Rank 41.28%
  • IV High 129.86% on 02/08/24
  • IV Low 6.06% on 05/22/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 11
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 121
  • Open Int (30-Day) 107

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.42
  • Number of Estimates 4
  • High Estimate 0.48
  • Low Estimate 0.34
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.16 +10.38%
on 11/05/24
25.98 -5.85%
on 11/12/24
+0.31 (+1.28%)
since 10/15/24
3-Month
17.69 +38.27%
on 08/16/24
25.98 -5.85%
on 11/12/24
+6.45 (+35.81%)
since 08/15/24
52-Week
9.49 +157.74%
on 11/30/23
25.98 -5.85%
on 11/12/24
+13.96 (+132.95%)
since 11/15/23

Most Recent Stories

More News
Phibro: Fiscal Q1 Earnings Snapshot

Phibro: Fiscal Q1 Earnings Snapshot

PAHC : 24.46 (-1.77%)
HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket

Henry Schein, Inc. HSIC registered adjusted earnings per share (EPS) of $1.22 in the third quarter of 2024, down 7.6% from the year-ago figure. However, the metric exceeded the Zacks Consensus Estimate...

VCYT : 35.94 (-2.97%)
HQY : 98.98 (+3.43%)
HSIC : 68.76 (+3.34%)
PAHC : 24.46 (-1.77%)
BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Bio-Rad Laboratories, Inc. BIO posted third-quarter 2024 adjusted earnings per share (EPS) of $2.01, which beat the Zacks Consensus Estimate by 57%. However, the bottom line decreased 13.7% from the prior-year...

VCYT : 35.94 (-2.97%)
HQY : 98.98 (+3.43%)
BIO : 320.31 (-8.54%)
PAHC : 24.46 (-1.77%)
Finding Great Top-Ranked Momentum Stocks to Buy Now

Wall Street is sitting on its hands on Monday and Tuesday waiting for Alphabet, Microsoft, Apple, Amazon, and other mega-cap technology stocks to report their results in the final week of October.See the...

PAHC : 24.46 (-1.77%)
WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action

Walgreens Boots Alliance, Inc. WBA delivered adjusted earnings per share (EPS) of 39 cents in the fourth quarter of fiscal 2024, down 41.8% from the year-ago quarter’s figure (down 40.8% at constant...

VCYT : 35.94 (-2.97%)
HQY : 98.98 (+3.43%)
WBA : 8.48 (-3.75%)
PAHC : 24.46 (-1.77%)
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now

Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in the Thrombectomy business. The company’s robust portfolio expansion looks promising. However, the impact...

AXGN : 12.64 (+1.36%)
PEN : 237.84 (+1.85%)
PAHC : 24.46 (-1.77%)
TMDX : 80.48 (-8.92%)
Reasons to Retain Chemed Stock in Your Portfolio Now

Chemed Corporation CHE is expected to grow in the upcoming quarters, backed by the prospects of the VITAS business. Strength within the company’s Roto-rooter brand looks impressive. Meanwhile, Chemed’s...

AXGN : 12.64 (+1.36%)
CHE : 557.95 (-0.77%)
PAHC : 24.46 (-1.77%)
TMDX : 80.48 (-8.92%)
Reasons to Retain QIAGEN Stock in Your Portfolio for Now

QIAGEN N.V. QGEN is well-poised to grow in the coming quarter, driven by its strategic alliances with researchers and pharma companies. The company’s expansive next-generation sequencing (NSG) portfolio...

AXGN : 12.64 (+1.36%)
PAHC : 24.46 (-1.77%)
QGEN : 41.27 (-1.95%)
TMDX : 80.48 (-8.92%)
New Animal Health Products, Vaccine Sales Support PAHC Stock

Phibro Animal Health's PAHC diversified product portfolio and wide presence in key growth areas bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy).Factors to Drive PAHC's GrowthPhibro’s...

AXGN : 12.64 (+1.36%)
PAHC : 24.46 (-1.77%)
TMDX : 80.48 (-8.92%)
KIDS : 22.93 (+1.06%)
Here's Why You Should Hold IART Stock in Your Portfolio Now

Integra LifeSciences Holdings Corporation IART is well-poised to grow in the coming quarter, driven by healthy sales growth within its Tissue Technologies business despite product recall and manufacturing...

AXGN : 12.64 (+1.36%)
IART : 22.88 (-1.68%)
PAHC : 24.46 (-1.77%)
TMDX : 80.48 (-8.92%)

Business Summary

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro...

See More

Key Turning Points

3rd Resistance Point 25.62
2nd Resistance Point 25.31
1st Resistance Point 24.88
Last Price 24.46
1st Support Level 24.14
2nd Support Level 23.83
3rd Support Level 23.40

See More

52-Week High 25.98
Last Price 24.46
Fibonacci 61.8% 19.68
Fibonacci 50% 17.74
Fibonacci 38.2% 15.79
52-Week Low 9.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar